Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling.
J Biol Chem. 2008 Jul 25; 283(30):20937-47
J Biol Chem. 2008 Jul 25; 283(30):20937-47
Thomas Pap and Marvin Peters, University Hospital Münster, Germany. F1000 Rheumatology & Clinical Immunology
17 Jul 2008 | New Finding
This study shows a novel pathway that could be important during tissue injury and/or remodelling by activation of PKCalpha leading to its association with beta 1 integrin, inhibiting cell adhesion and reinforcement of actin-stress fiber organization.
In this article the authors show a model for a novel RGD-independent cell adhesion process, whereby transglutaminase (TG)-fibronectin (FN) binding to the heparin sulphate chains of syndecan-4.
They find that cell signalling leads to the activation of FAK and ERK1/2 MAP Kinases. They also show that the ablation of c-Raf-1 diminishese the ability of a TG-FN matrix to rescue cell adhesion in the presence of RGD-containing peptides.
Acknowledgements: Katja Neugebauer
Peters M, Pap T: "This study shows a novel pathway that could be important during tissue injury and/..." Evaluation of: [Telci D et al. Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. J Biol Chem. 2008 Jul 25; 283(30):20937-47; doi: 10.1074/jbc.M801763200]. Faculty of 1000, 17 Jul 2008. F1000.com/1115598#eval571651
Short form
Peters M, Pap T: 2008. F1000.com/1115598#eval571651
Faculty of 1000 evaluations, dissents and comments for [Telci D et al. Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. J Biol Chem. 2008 Jul 25; 283(30):20937-47; doi: 10.1074/jbc.M801763200]. Faculty of 1000, 17 Jul 2008. F1000.com/1115598
Short form
Faculty of 1000: 2008. F1000.com/1115598
Heterotropic association of tissue transglutaminase (TG2) with extracellular matrix-associated fibronectin (FN) can restore the adhesion of fibroblasts when the integrin-mediated direct binding to FN is impaired using RGD-containing peptide. We demonstrate that the compensatory effect of the TG-FN complex in the presence of RGD-containing peptides is mediated by TG2 binding to the heparan sulfate chains of the syndecan-4 cell surface receptor. This binding mediates activation of protein kinase Calpha (PKCalpha) and its subsequent interaction with beta(1) integrin since disruption of PKCalpha binding to beta(1) integrins with a cell-permeant competitive peptide inhibits cell adhesion and the associated actin stress fiber formation. Cell signaling by this process leads to the activation of focal adhesion kinase and ERK1/2 mitogen-activated protein kinases. Fibroblasts deficient in Raf-1 do not respond fully to the TG-FN complex unless either the full-length kinase competent Raf-1 or the kinase-inactive domain of Raf-1 is reintroduced, indicating the involvement of the Raf-1 protein in the signaling mechanism. We propose a model for a novel RGD-independent cell adhesion process that could be important during tissue injury and/or remodeling whereby TG-FN binding to syndecan-4 activates PKCalpha leading to its association with beta(1) integrin, reinforcement of actin-stress fiber organization, and MAPK pathway activation.
DOI: 10.1074/jbc.M801763200
PMID: 18499669
Aspect(s) of health care
Study population
Article Type
Sign in/get access to leave a comment.
No comments yet.